Related Experiment Videos
A fibrin-based bioengineered ocular surface with human corneal epithelial stem cells
Bin Han1, Ivan R Schwab, Trista K Madsen
1Tissue Bioengineering Laboratory, Department of Ophthalmology, University of California-Davis, One Shields Avenue, Davis, CA 95616, USA.
Cornea
|June 20, 2002
Summary
Researchers developed a bioengineered ocular surface using human corneal stem cells in fibrin gel. This pliable, stable tissue replacement shows potential for autologous transplantation.
Area of Science:
- Ophthalmology
- Tissue Engineering
- Regenerative Medicine
Background:
- Corneal diseases necessitate innovative tissue replacements.
- Current treatments face limitations in availability and efficacy.
- Bioengineering offers a promising avenue for creating functional ocular tissues.
Purpose of the Study:
- To prepare a bioengineered ocular surface tissue replacement.
- Utilize presumed human corneal epithelial stem cells within a cross-linked fibrin gel.
- Develop a potential transplantable tissue for ocular surface reconstruction.
Main Methods:
- Harvesting and culturing presumed human corneal epithelial stem cells from donor corneas.
- Suspending cells in a fibronectin/fibrin gel cross-linked by factor XIII.
- Cultivating cells within the gel for 15 days and performing immunostaining for keratins.
Main Results:
- The fibrin gel construct with corneal stem cells was manageable and maneuverable.
- Cells stained positive for keratin 3 (AE5), indicating corneal epithelial differentiation.
- Keratin 19 positivity in central cells suggested a primitive stem cell population.
Conclusions:
- A bioengineered ocular surface using corneal stem cells in fibrin gel is a potential improvement for tissue replacement.
- The construct is transportable, pliable, and stable.
- The use of human-derived cells and plasma components allows for potential autologous transplantation.